| Lisa Collums Rhea, NP-C | |
|
8 Front St, Belmont, MS 38827 | |
| (662) 454-1170 | |
| (662) 454-1062 |
| Full Name | Lisa Collums Rhea |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 8 Front St, Belmont, Mississippi |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477907616 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 901494 (Mississippi) | Primary |
| Entity Name | Mississippi Emergency Physician Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710220678 PECOS PAC ID: 2264672492 Enrollment ID: O20130710000827 |
News Archive
If you have a relative with cancer, probably one of the most pressing questions is what your chances are of getting it yourself. In a paper published in PloS Medicine, the premier medical journal freely available online, Laufey Amundadottir and colleagues from deCODE genetics (a company that is using genetics to develop new drug treatments) and Iceland's National-University Hospital go some way toward answering that question.
A new analysis has found that certain cancers are more concentrated in areas with high poverty, while other cancers arise more often in wealthy regions. Also, areas with higher poverty had lower cancer incidence and higher mortality than areas with lower poverty.
Home Diagnostics, Inc., a leading manufacturer and marketer of diabetes testing supplies, announced today that it signed a definitive merger agreement with Nipro Corporation (Tokyo Stock Exchange and Osaka Stock Exchange Ticker Code 8086), a global manufacturer and distributor of medical devices, pharmaceutical products and medical and glass products headquartered in Osaka, Japan, under which Nipro will acquire all outstanding shares of Home Diagnostics' common stock, $.01 par value, for a cash purchase price of $11.50 per share (or aggregate consideration of approximately $215 million).
The U.S. Food and Drug Administration is advising consumers and health care professionals not to use any liquid drug or dietary supplement products manufactured by PharmaTech LLC of Davie, Florida, and labeled by Rugby Laboratories, Major Pharmaceuticals and Leader Brands, due to potential contamination with the bacteria Burkholderia cepacia (B. cepacia) and the risk for severe patient infection.
› Verified 6 days ago
| Entity Name | Ms Medical Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144705120 PECOS PAC ID: 9537413786 Enrollment ID: O20181107001260 |
News Archive
If you have a relative with cancer, probably one of the most pressing questions is what your chances are of getting it yourself. In a paper published in PloS Medicine, the premier medical journal freely available online, Laufey Amundadottir and colleagues from deCODE genetics (a company that is using genetics to develop new drug treatments) and Iceland's National-University Hospital go some way toward answering that question.
A new analysis has found that certain cancers are more concentrated in areas with high poverty, while other cancers arise more often in wealthy regions. Also, areas with higher poverty had lower cancer incidence and higher mortality than areas with lower poverty.
Home Diagnostics, Inc., a leading manufacturer and marketer of diabetes testing supplies, announced today that it signed a definitive merger agreement with Nipro Corporation (Tokyo Stock Exchange and Osaka Stock Exchange Ticker Code 8086), a global manufacturer and distributor of medical devices, pharmaceutical products and medical and glass products headquartered in Osaka, Japan, under which Nipro will acquire all outstanding shares of Home Diagnostics' common stock, $.01 par value, for a cash purchase price of $11.50 per share (or aggregate consideration of approximately $215 million).
The U.S. Food and Drug Administration is advising consumers and health care professionals not to use any liquid drug or dietary supplement products manufactured by PharmaTech LLC of Davie, Florida, and labeled by Rugby Laboratories, Major Pharmaceuticals and Leader Brands, due to potential contamination with the bacteria Burkholderia cepacia (B. cepacia) and the risk for severe patient infection.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lisa Collums Rhea, NP-C 8 Front St, Belmont, MS 38827-7764 Ph: (662) 454-1170 | Lisa Collums Rhea, NP-C 8 Front St, Belmont, MS 38827 Ph: (662) 454-1170 |
News Archive
If you have a relative with cancer, probably one of the most pressing questions is what your chances are of getting it yourself. In a paper published in PloS Medicine, the premier medical journal freely available online, Laufey Amundadottir and colleagues from deCODE genetics (a company that is using genetics to develop new drug treatments) and Iceland's National-University Hospital go some way toward answering that question.
A new analysis has found that certain cancers are more concentrated in areas with high poverty, while other cancers arise more often in wealthy regions. Also, areas with higher poverty had lower cancer incidence and higher mortality than areas with lower poverty.
Home Diagnostics, Inc., a leading manufacturer and marketer of diabetes testing supplies, announced today that it signed a definitive merger agreement with Nipro Corporation (Tokyo Stock Exchange and Osaka Stock Exchange Ticker Code 8086), a global manufacturer and distributor of medical devices, pharmaceutical products and medical and glass products headquartered in Osaka, Japan, under which Nipro will acquire all outstanding shares of Home Diagnostics' common stock, $.01 par value, for a cash purchase price of $11.50 per share (or aggregate consideration of approximately $215 million).
The U.S. Food and Drug Administration is advising consumers and health care professionals not to use any liquid drug or dietary supplement products manufactured by PharmaTech LLC of Davie, Florida, and labeled by Rugby Laboratories, Major Pharmaceuticals and Leader Brands, due to potential contamination with the bacteria Burkholderia cepacia (B. cepacia) and the risk for severe patient infection.
› Verified 6 days ago
Heather Larue Edmondson, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 102 3rd St, Belmont, MS 38827 Phone: 662-454-3401 | |
Whitney Bonner Sparks, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 26 3rd St, Belmont, MS 38827 Phone: 662-454-4520 Fax: 662-454-4521 | |
Lacy Diane Estes, APRN, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 26 3rd St, Belmont, MS 38827 Phone: 662-454-4520 Fax: 662-454-4521 | |
Dr. Toni Armstrong, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 8 Front St, Belmont, MS 38827 Phone: 662-454-1170 | |
Angela James, FNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 26 3rd St, Belmont, MS 38827 Phone: 662-454-7170 | |
Misty Leigh Glidewell, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 8 Front St, Belmont, MS 38827 Phone: 662-454-1170 Fax: 662-454-1062 |